{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:49:55Z","timestamp":1791611395982,"version":"4.3.4"},"reference-count":35,"publisher":"The Fukushima Society of Medical Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2026]]},"DOI":"10.5387\/fms.26-00014","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T22:09:42Z","timestamp":1779833382000},"page":"289-294","source":"Crossref","is-referenced-by-count":0,"title":["Clonal hematopoiesis and circulating biomarkers in cardiovascular diseases"],"prefix":"10.5387","volume":"72","author":[{"given":"Tetsuro","family":"Yokokawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"},{"name":"Department of Community Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Misaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wong ND, Zhao Y, Quek RGW, <i>et al.<\/i>\u2003Residual atherosclerotic cardiovascular disease risk in statin-treated adults:The Multi-Ethnic Study of Atherosclerosis.\u2003J Clin Lipidol <b>11<\/b>(5):1223-1233, 2017.","DOI":"10.1016\/j.jacl.2017.06.015"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Steensma DP, Bejar R, Jaiswal S, <i>et al.<\/i>\u2003Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.\u2003Blood, <b>126<\/b>(1):9-16, 2015.","DOI":"10.1182\/blood-2015-03-631747"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Jaiswal S, Fontanillas P, Flannick J, <i>et al.<\/i>\u2003Age-related clonal hematopoiesis associated with adverse outcomes.\u2003N Engl J Med, <b>371<\/b>(26):2488-2498, 2014.","DOI":"10.1056\/NEJMoa1408617"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jaiswal S, Natarajan P, Silver AJ, <i>et al.<\/i>\u2003Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.\u2003N Engl J Med, <b>377<\/b>(2):111-121, 2017.","DOI":"10.1056\/NEJMoa1701719"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sano S, Oshima K, Wang Y, <i>et al.<\/i>\u2003Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a\u00a0Mechanism Involving the IL-1\u03b2\/NLRP3\u00a0Inflammasome.\u2003J Am Coll Cardiol, <b>71<\/b>(8):875-886, 2018.","DOI":"10.1016\/j.jacc.2017.12.037"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sugita J, Chen Z, Setoguchi N, <i>et al.<\/i>\u2003Cardiopulmonary neuro-immune reflex:From afferent stress signaling to peripheral myeloid memory.\u2003J Cardiol, <b>87<\/b>(1):77-84, 2026.","DOI":"10.1016\/j.jjcc.2025.08.013"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Misaka T, Kimishima Y, Yokokawa T, <i>et al.<\/i>\u2003Clonal hematopoiesis and cardiovascular diseases:role of JAK2V617F.\u2003J Cardiol, <b>81<\/b>(1):3-9, 2023.","DOI":"10.1016\/j.jjcc.2022.02.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sano S, Wang Y, Yura Y, <i>et al.<\/i>\u2003JAK2 (V617F) -Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart\u00a0Failure.\u2003JACC Basic Transl Sci, <b>4<\/b>(6):684-697, 2019.","DOI":"10.1016\/j.jacbts.2019.05.013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fuster JJ, MacLauchlan S, Zuriaga MA, <i>et al.<\/i>\u2003Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.\u2003Science, <b>355<\/b>(6327):842-847, 2017.","DOI":"10.1126\/science.aag1381"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Potus F, Pauciulo MW, Cook EK, <i>et al.<\/i>\u2003Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension.\u2003Circulation, <b>141<\/b>(24):1986-2000, 2020.","DOI":"10.1161\/CIRCULATIONAHA.119.044320"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yokokawa T, Boucherat O, Martineau S, <i>et al.<\/i>\u2003Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.\u2003J Am Heart Assoc, <b>13<\/b>(12):e032888, 2024.","DOI":"10.1161\/JAHA.123.032888"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kuwabara Y, Yokokawa T, Lemay SE, <i>et al.<\/i>\u2003Exploratory Study of Prognostic Plasma Biomarkers in Patients with Pulmonary Arterial Hypertension.\u2003Am J Pathol, <b>195<\/b>(8):1376-1393, 2025.","DOI":"10.1016\/j.ajpath.2025.04.018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Meijers WC, Bayes-Genis A, Mebazaa A, <i>et al.<\/i>\u2003Circulating heart failure biomarkers beyond natriuretic peptides:review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC).\u2003Eur J Heart Fail, <b>23<\/b>(10):1610-1632, 2021.","DOI":"10.1002\/ejhf.2346"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miyazaki S, Inaba S, Higashi H, <i>et al.<\/i>\u2003Validation of N-Terminal Pro B-Type Natriuretic Peptide Threshold for Early Detection of Pre-Heart Failure in a General Japanese Population - Toon Health Study.\u2003Circ J, <b>89<\/b>(7):966-972, 2025.","DOI":"10.1253\/circj.CJ-24-0774"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Boucherat O, Yokokawa T, Krishna V, <i>et al.<\/i>\u2003Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension.\u2003Nat Cardiovasc Res, <b>1<\/b>(8):748-760, 2022.","DOI":"10.1038\/s44161-022-00113-w"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nakao T, Yu Z, Vlasschaert C, <i>et al.<\/i>\u2003Increased Risk of\u00a0Thoracic Aortic Aneurysms With JAK2\u00a0V617F.\u2003J Am Coll Cardiol, <b>81<\/b>(21):2128-2130, 2023.","DOI":"10.1016\/j.jacc.2023.03.413"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yokokawa T, Misaka T, Kimishima Y, <i>et al.<\/i>\u2003Clonal Hematopoiesis and JAK2V617F Mutations in Patients With Cardiovascular Disease.\u2003JACC CardioOncol, <b>3<\/b>(1):134-136, 2021.","DOI":"10.1016\/j.jaccao.2021.01.001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Obel LM, Skovbo JS, Diederichsen ACP, <i>et al.<\/i>\u2003Aortic Aneurysm Risk and the Somatic JAK2 (V617F) Mutation:Insights From a Multicenter, Population-Based Cardiovascular Screening Study.\u2003Circulation, <b>152<\/b>(5):300-312, 2025.","DOI":"10.1161\/CIRCULATIONAHA.125.074002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yokokawa T, Misaka T, Kimishima Y, <i>et al.<\/i>\u2003Crucial role of hematopoietic JAK2 V617F in the development of aortic aneurysms.\u2003Haematologica, <b>106<\/b>(7):1910-1922, 2021.","DOI":"10.3324\/haematol.2020.264085"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ueda K, Ikeda K, Ikezoe T, <i>et al.<\/i>\u2003Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms.\u2003Blood Adv, <b>1<\/b>(15):\u20021001-1015, 2017.","DOI":"10.1182\/bloodadvances.2017004457"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Shide K, Shimoda HK, Kumano T, <i>et al.<\/i>\u2003Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F.\u2003Leukemia, <b>22<\/b>(1):87-95, 2008.","DOI":"10.1038\/sj.leu.2405043"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Rauch PJ, Gopakumar J, Silver AJ, <i>et al.<\/i>\u2003Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes.\u2003Nat Cardiovasc Res, <b>2<\/b>(9):805-818, 2023.","DOI":"10.1038\/s44161-023-00326-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lemay SE, Montesinos MS, Grobs Y, <i>et al.<\/i>\u2003Exploring Integrin \u03b15\u03b21 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension:Insights From Comprehensive Multicenter Preclinical Studies.\u2003Circulation, <b>151<\/b>(16):1162-1183, 2025.","DOI":"10.1161\/CIRCULATIONAHA.124.070693"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Montani D, Thor\u00e9 P, Mignard X, <i>et al.<\/i>\u2003Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms:A Population-based Study.\u2003Am J Respir Crit Care Med, <b>208<\/b>(5):600-612, 2023.","DOI":"10.1164\/rccm.202210-1941OC"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Minakawa K, Yokokawa T, Ueda K, <i>et al.<\/i>\u2003Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice.\u2003J Hematol Oncol, <b>14<\/b>(1):52, 2021.","DOI":"10.1186\/s13045-021-01064-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kimishima Y, Misaka T, Yokokawa T, <i>et al.<\/i>\u2003Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils.\u2003Nat Commun, <b>12<\/b>(1):6177, 2021.","DOI":"10.1038\/s41467-021-26435-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yokokawa T, Nishiura K, Akama J, <i>et al.<\/i>\u2003Significance of 14-3-3 Epsilon for Right Ventricular Failure Associated with Pulmonary Hypertension.\u2003Intern Med, 2026.","DOI":"10.2169\/internalmedicine.6383-25"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Niu Y, Tian J, Provencher S, <i>et al.<\/i>\u2003Protein biomarkers in pulmonary arterial hypertension:\u2002advances, clinical relevance, and translational challenges.\u2003J Transl Med, <b>23<\/b>(1):1288, 2025.","DOI":"10.1186\/s12967-025-07257-w"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Zemmour H, Planer D, Magenheim J, <i>et al.<\/i>\u2003Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA.\u2003Nat Commun, <b>9<\/b>(1):1443, 2018.","DOI":"10.1038\/s41467-018-03961-y"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yokokawa T, Misaka T, Kimishima Y, <i>et al.<\/i>\u2003Clinical Significance of Circulating Cardiomyocyte-Specific Cell-Free DNA in Patients With Heart Failure:A Proof-of-Concept Study.\u2003Can J Cardiol, <b>36<\/b>(6):931-935, 2020.","DOI":"10.1016\/j.cjca.2019.10.016"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Deng L, Wang Z, Boucherat O, <i>et al.<\/i>\u2003IGFBP7 Contributes to EndMT and Serves as Biomarker for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.\u2003Am J Respir Cell Mol Biol, 2025.","DOI":"10.1165\/rcmb.2025-0004LE"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Jafari L, Wiedenroth CB, Kriechbaum SD, <i>et al.<\/i>\u2003Transcriptional changes of the extracellular matrix in chronic thromboembolic pulmonary hypertension govern right ventricle remodeling and recovery.\u2003Nat Cardiovasc Res, <b>4<\/b>(7):857-875, 2025.","DOI":"10.1038\/s44161-025-00672-8"},{"key":"33","unstructured":"33. Toro V, Mougin M, Brossat C, <i>et al.<\/i>\u2003Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.\u2003Circulation, 2026."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yokokawa T, Nishiura K, Katahira M, <i>et al.<\/i>\u2003Collagen Triple Helix Repeat-Containing Protein 1 Is a Novel Biomarker of Right Ventricular Involvement in Pulmonary Hypertension.\u2003Can J Cardiol, <b>40<\/b>(11):2281-2288, 2024.","DOI":"10.1016\/j.cjca.2024.04.016"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kiko T, Asano R, Yoshikawa Y, <i>et al.<\/i>\u2003Survival trends in patients with chronic thromboembolic pulmonary hypertension:an observational study.\u2003Eur Respir J, <b>66<\/b>(1):2402268, 2025.","DOI":"10.1183\/13993003.02268-2024"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/72\/4\/72_26-00014\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:07:39Z","timestamp":1791608859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/72\/4\/72_26-00014\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.26-00014","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26-00014"}}